タイトル
検索に戻る
検索結果

結果:97件
(81から97までを表示します.)

←前の検索結果へ


International Session13
Immunotherapy
座長:Marina Chiara Garassino1, Nobuhiko Seki2(IRCCS National Cancer Institute(INT)Milan, Italy1, Department of Internal Medicine, Teikyo University School of Medicine, Japan2
*Akira Kisohara・Takashi Masuda・Takayuki Kurosawa・Teruaki Isida・Yuu Kawada・Syuumei Kan・Kouhei Tagawa・Katsuhiko Aoyama
Respiratory Department, Kasukabe Medical Center, Japan
第60回日本肺癌学会学術集会 2019年12月開催

International Session14
Novel therapeutic targets
座長:Ryohei Katayama1, Atsushi Osoegawa2(Div. of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Japan1, Kyushu University, Graduate School of Medical Sciences, Department of Surgery and Science, Japan2
*Zeinab Kosibaty・Masayuki Noguchi
Department of pathology, University of Tsukuba, Ibaraki, Japan
第60回日本肺癌学会学術集会 2019年12月開催

International Session14
Novel therapeutic targets
座長:Ryohei Katayama1, Atsushi Osoegawa2(Div. of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Japan1, Kyushu University, Graduate School of Medical Sciences, Department of Surgery and Science, Japan2
*Yanping Wu・Xiang Wang・Yong Li・Zhonghui Liu・Lianjun Lin・Xinmin Liu
Department of Geriatrics, Peking University First Hospital, China
第60回日本肺癌学会学術集会 2019年12月開催

International Session14
Novel therapeutic targets
座長:Ryohei Katayama1, Atsushi Osoegawa2(Div. of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Japan1, Kyushu University, Graduate School of Medical Sciences, Department of Surgery and Science, Japan2
*Jinghan Li・Haichao Sun・Gebang Wang・Chenlei Zhang・Yi Zhang・Guan Wang・Peng Zu・Hongxu Liu
Department of Thoracic Surgery, Cancer Hospital of China Medical University,Liaoning Cancer Hospital & Institute, China
第60回日本肺癌学会学術集会 2019年12月開催

International Session14
Novel therapeutic targets
座長:Ryohei Katayama1, Atsushi Osoegawa2(Div. of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Japan1, Kyushu University, Graduate School of Medical Sciences, Department of Surgery and Science, Japan2
*Chunxia Su・Juan Zhou・Xiangling Chu・Jing Zhao
Department of Medical Oncology, Shanghai Pulmonary Hospital & Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai, China
第60回日本肺癌学会学術集会 2019年12月開催

International Session14
Novel therapeutic targets
座長:Ryohei Katayama1, Atsushi Osoegawa2(Div. of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Japan1, Kyushu University, Graduate School of Medical Sciences, Department of Surgery and Science, Japan2
*Taichiro Goto・Rumi Higuchi・Sotaro Otake・Harunobu Sasanuma
Department of General Thoracic Surgery, Yamanashi Prefectural Central Hospital, Japan
第60回日本肺癌学会学術集会 2019年12月開催

International Session14
Novel therapeutic targets
座長:Ryohei Katayama1, Atsushi Osoegawa2(Div. of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Japan1, Kyushu University, Graduate School of Medical Sciences, Department of Surgery and Science, Japan2
*Kuijin Kim1・Jihyun Kwon2・Jihye Sung1・Soyeon Kim3・Jong Seok Lee4
Medical Research Collaborating Center, Seoul National University Bundang Hospital, Seongnam, Republic of Korea1;Hematology and Oncology, Department of Internal Medicine, Chungbuk National University Hospital, Cheongju, Republic of Korea2;Cancer Research Institute, Seoul National University College of Medicine, Seoul, , Republic of Korea3;Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Republic of Korea4
第60回日本肺癌学会学術集会 2019年12月開催

International Session15
Drug resistance
座長:Kenichi Suda1, Shigeki Nanjo2(Division of Thoracic Surgery, Department of Surgery, KINDAI University Faculty of Medicine, Japan1, Division of Hematology/Oncology, University of Califonia San Francisco, United States of America2

第60回日本肺癌学会学術集会 2019年12月開催

International Session15
Drug resistance
座長:Kenichi Suda1, Shigeki Nanjo2(Division of Thoracic Surgery, Department of Surgery, KINDAI University Faculty of Medicine, Japan1, Division of Hematology/Oncology, University of Califonia San Francisco, United States of America2
*Atsushi Osoegawa1・Masafumi Yamaguchi2・Tomomi Nakamura3・Ryotaro Morinaga4・Kentaro Tanaka5・Kosuke Kashiwabara6・Kenichi Taguchi7・Kazuki Nabeshima8・Junji Kishimoto9・Kenji Sugio10
Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Japan1;Department of Thoracic Oncology, National Kyushu Cancer Center, Japan2;Division of Respiratory Medicine, Saga University Hospital, Japan3;Department of Thoracic Medical Oncology, Oita Prefectural Hospital, Japan4;Department of Respiratory Medicine, Kyushu University Hospital, Japan5;Department of Respiratory Medicine, Kumamoto Regional Medical Center, Japan6;Department of Pathology, National Kyushu Cancer Center, Japan7;Department of Pathology, Fukuoka University Hospital, Japan8;Department of Research and Development of Next Generation Medicine, Kyushu University, Japan9;Department of Thoracic and Breast Surgery, Oita University Faculty of Medicine, Japan10
第60回日本肺癌学会学術集会 2019年12月開催

International Session15
Drug resistance
座長:Kenichi Suda1, Shigeki Nanjo2(Division of Thoracic Surgery, Department of Surgery, KINDAI University Faculty of Medicine, Japan1, Division of Hematology/Oncology, University of Califonia San Francisco, United States of America2
*Bo Mi Ku1・Kyoung Young Lee1・Jiae Koh1・Mi Soon Kim1・Jae Yeong Heo1・Hyun Ae Jung2・Jong-Mu Sun2・Se-Hoon Lee2・Jin Seok Ahn2・Keunchil Park2・Myung-Ju Ahn2
Research Institute for Future Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Republic of Korea1;Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Republic of Korea2
第60回日本肺癌学会学術集会 2019年12月開催

International Session15
Drug resistance
座長:Kenichi Suda1, Shigeki Nanjo2(Division of Thoracic Surgery, Department of Surgery, KINDAI University Faculty of Medicine, Japan1, Division of Hematology/Oncology, University of Califonia San Francisco, United States of America2
*Kosuke Tanaka1,2・Song Han1・Yogesh Ganesan1・Helena Yu3・Mark Chris3・James Hsieh4・Emily Cheng1,5,6
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, United States of America1;Overseas research fellow, Japan Society for the Promotion of Science, Japan2;Thoracic Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, United States of America3;Molecular Oncology, Department of Medicine, Washington University, United States of America4;Department of Medicine, Weill Cornell Medicine College, United States of America5;Department of Pathology, Memorial Sloan-Kettering Cancer Center, United States of America6
第60回日本肺癌学会学術集会 2019年12月開催

International Session15
Drug resistance
座長:Kenichi Suda1, Shigeki Nanjo2(Division of Thoracic Surgery, Department of Surgery, KINDAI University Faculty of Medicine, Japan1, Division of Hematology/Oncology, University of Califonia San Francisco, United States of America2
*Wei Guo・Su Yang・Hecheng Li
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China
第60回日本肺癌学会学術集会 2019年12月開催

International Session15
Drug resistance
座長:Kenichi Suda1, Shigeki Nanjo2(Division of Thoracic Surgery, Department of Surgery, KINDAI University Faculty of Medicine, Japan1, Division of Hematology/Oncology, University of Califonia San Francisco, United States of America2
*Yusoo Lee1・Tae Min Kim1,2・Dong-Wan Kim1,2・Soyeon Kim1,3・Miso Kim1,2・Bhumsuk Keam1,2・Ja-Lok Ku1・Dae Seog Heo1,2
Seoul National University Cancer Research Institute, Republic of Korea1;Department of Internal Medicine, Seoul National University Hospital, Republic of Korea2;Biomedical Research Institute, Seoul National University Hospital, Republic of Korea3
第60回日本肺癌学会学術集会 2019年12月開催

International Session16
Novel therapeutic approach
座長:Ryuji Hayashi1, Keunchil Park2(Clinical Oncology Toyama University Hosptal, Japan1, Samsung Medical Center, Sungkyunkwan University School of Medicine, Republic of Korea2
*Akito Hata1・Takashi Niwa2・Hiroshige Yoshioka3・Masahiko Ando4・Nobuyuki Yamamoto5・NICE Salvage study member6
Kobe Minimally Invasive Cancer Center, Japan1;Kanagawa Cardiovascular and Respiratory Center, Japan2;Kansai Medical University, Japan3;Nagoya University, Japan4;Wakayama Medical University, Japan5;NICE Salvage study group, Japan6
第60回日本肺癌学会学術集会 2019年12月開催

International Session16
Novel therapeutic approach
座長:Ryuji Hayashi1, Keunchil Park2(Clinical Oncology Toyama University Hosptal, Japan1, Samsung Medical Center, Sungkyunkwan University School of Medicine, Republic of Korea2

第60回日本肺癌学会学術集会 2019年12月開催

International Session16
Novel therapeutic approach
座長:Ryuji Hayashi1, Keunchil Park2(Clinical Oncology Toyama University Hosptal, Japan1, Samsung Medical Center, Sungkyunkwan University School of Medicine, Republic of Korea2
*Sehhoon Park1・Joonho Shim2,3・Peter G. S. Mortimer4・Simon A Smith5・Robert E Godin4・Simon J. Hollingsworth6・Hee-Jung Kim7・Hyun Ae Jung1・Jong-Mu Sun1・Woong-Yang Park2,3・Jin Seok Ahn1・Myung-Ju Ahn1・Se-Hoon Lee1,2・Keunchil Park1,2
Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea1;Department of Health Science and Technology, Samsung Advanced Institute of Health Science and Technology, Sungkyunkwan University, Seoul, Republic of Korea2;Samsung Genome Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea3;Early oncology clinical, R&D Oncology, AstraZeneca, Cambridge, United Kingdom4;Early oncology clinical, R&D Oncology, AstraZeneca, Boston, United States of America5;Oncology Business Unit, AstraZeneca, Cambridge, United Kingdom6;External R&D, R&D Oncology, AstraZeneca, Seoul, Republic of Korea7
第60回日本肺癌学会学術集会 2019年12月開催

International Session16
Novel therapeutic approach
座長:Ryuji Hayashi1, Keunchil Park2(Clinical Oncology Toyama University Hosptal, Japan1, Samsung Medical Center, Sungkyunkwan University School of Medicine, Republic of Korea2

第60回日本肺癌学会学術集会 2019年12月開催

ページの先頭へ